CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Millions, unless otherwise specified	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Cash flows from operating activities:
Consolidated net income	$ 25.0	$ 34.3
Adjustments to reconcile consolidated net income to cash flows from operating activities:
Depreciation and amortization	28.6	25.7
Amortization of deferred financing costs	0.3	0.3
Write-down of inventories to net realizable value	14.1	19.4
Stock-based compensation	3.8	3.8
Deferred income taxes	(0.4)	(4.3)
Other non-cash expense	0.8	0.7
Changes in operating assets and liabilities:
Accounts receivable	36.6	(28.4)
Inventories	(58.6)	(82.0)
Accounts payable	4.0	13.0
Customer advances	22.2	2.9
Other changes in operating assets and liabilities, net	(34.5)	(11.0)
Net cash provided by (used in) operating activities	41.9	(25.6)
Cash flows from investing activities:
Acquisitions, net of cash acquired	(21.7)	(1.3)
Purchases of property, plant and equipment	(30.4)	(33.1)
Sales of property, plant and equipment	1.7	1.9
Net cash used in investing activities	(50.4)	(32.5)
Cash flows from financing activities:
Repayments of revolving lines of credit, net	(196.5)	(0.3)
Proceeds from Note Purchase Agreement	240.0
Repayment of other debt, net	(26.3)	(13.7)
Payment of deferred financing costs	(1.4)	(1.2)
Proceeds from issuance of common stock, net	3.4	3.0
Changes in restricted cash	(1.1)	(1.4)
Cash payments to noncontrolling interest	(0.6)	(0.4)
Net cash provided by (used in) financing activities	17.5	(14.0)
Effect of exchange rate changes on cash and cash equivalents	(14.7)	11.5
Net change in cash and cash equivalents	(5.7)	(60.6)
Cash and cash equivalents at beginning of period	246.0	230.4
Cash and cash equivalents at end of period	240.3	169.8
Non-cash financing activities:
Issuance of common stock in connection with acquisition of Michrom Bioresources Inc.		$ 2.9